Australia markets closed

Vertex Pharmaceuticals Incorporated (0QZU.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
291.61+7.35 (+2.59%)
As of 07:11PM BST. Market open.
Full screen
Previous close284.26
Bid0.00 x 0
Ask0.00 x 0
Day's range287.84 - 293.51
52-week range287.84 - 293.51
Avg. volumeN/A
Market cap749.453M
Beta (5Y monthly)0.45
PE ratio (TTM)0.31
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Vertex (VRTX), CRISPR to Seek FDA Nod for Hemoglobinopathy Therapy

    Vertex (VRTX) and partner CRISPR intend to start a rolling BLA submission with the FDA for their gene therapy in thalassemia and sickle cell disease indications by November 2022.

  • Motley Fool

    3 Biotech Stocks to Buy and Hold for the Next 10 Years

    Several biotech stocks have outperformed the struggling market this year. This list includes Vertex Pharmaceuticals (NASDAQ: VRTX), Exelixis (NASDAQ: EXEL), and Amgen (NASDAQ: AMGN). Let's consider why these three biotechs are solid buys for the next decade.

  • Motley Fool

    The 2 Best Stocks to Invest $5,000 in Right Now

    Between rumors of a recession, rising interest rates, and inflation, it's tough to find stocks that you're confident will keep growing instead of going to zero. Vertex Pharmaceuticals (NASDAQ: VRTX) is worth a $2,500 investment because it's the world's largest public business devoted to curing rare diseases, and it's proven to be quite adept at that goal so far.